CLINICAL_TRIALS
trial_result
· 2024-07-10
Clinical Trial Update: Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) [Phase 3]
Summary
Phase 3 trial data evaluate the efficacy and safety of nemolizumab in participants with prurigo nodularis; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Prurigo Nodularis | Phase 3 | Status: COMPLETED | Results posted: 2024-07-10